N/A
N=498
Leveraging Social Networks to Increase COVID-19 Testing Uptake
Covid-19 · Substance Use · Opioid Use
Bottom Line
View on ClinicalTrials.gov: NCT04873401 ↗Enrolled (actual)
498
Serious AEs
0.0%
Results posted
Apr 2023
Primary outcome: Primary: Participants Who Agreed to Take a COVID-19 Rapid Test of Those Enrolled — 261; 214 participants who tested — p=0.928
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Chain-referral (Behavioral); Credible Messenger (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- New York State Psychiatric Institute
- Primary completion
- Mar 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Participants Who Agreed to Take a COVID-19 Rapid Test of Those Enrolled |
261; 214 | 0.928 |
| PRIMARY Mean Number of COVID-19 Rapid Tests Taken |
1.8; 1.6 | 0.240 |
| PRIMARY Uptake of the Recruitment Strategy Into the Community |
271; 227 | 0.367 |
| PRIMARY Reach of the Recruitment Strategy Into the Community |
624; 468 | 0.005 sig |
| SECONDARY Participant Acceptability of Recruitment Strategy and Testing Program Scale |
— | — |
| SECONDARY Sustainability of the Testing Program |
— | — |
| SECONDARY Feasibility of Recruitment and Testing Protocols |
— | — |
Summary
This two-year project will adapt and conduct a trial examining the ability of two recruitment strategies, chain-referral and credible messenger, to reach those who use opioids and other substances in order to increase their uptake of onsite point of care COVID-19 testing that will be delivered in two community based organizations (CBOs): Alliance for Positive Change and Argus Health Inc. In Phase 1, Adapt two implementation strategies to support COVID-19 testing uptake and sustainability, adapting elements of existing efficacious social network-based interventions via a CBPR approach. In Phase 2, we will examine and compare the efficacy of two sets of implementation strategies on (i) reach, (ii) testing uptake, (iii) service delivery (i.e. quarantine, medical care, contact tracing) and (iv) sustainability for individuals who use opioids and other drugs. In Phase 3, Elucidate and compare the system/organizational-, staff-, and individual-level factors that influence implementation (i.e. fidelity, acceptability, feasibility, sustainability) of the strategies to develop a plan for dissemination and scale-up in other CBOs who serve opioid and other substance using individuals in NYC.
Eligibility Criteria
Inclusion Criteria
- Endorse opioid use in the past 6 months
- Speak English or Spanish
- Age 18+
Exclusion Criteria
- Deny history of opioid use (but will be offered COVID-19 testing)
Data sourced from ClinicalTrials.gov (NCT04873401). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.